Loading...
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial vulnerability assessment tool by 360 Security Group (Qihoo 360). Rapid7 InsightVM is a commercial vulnerability assessment tool by Rapid7. Compare features, ratings, integrations, and community reviews side by side to find the best vulnerability assessment fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Mid-market and enterprise teams drowning in vulnerability backlogs will see immediate ROI from InsightVM's Active Risk scoring, which actually deprioritizes low-context vulnerabilities instead of treating every CVE as equally urgent. The AI-driven CVSS adjustments and remediation workflow automation with SLA tracking cut triage time meaningfully, and Rapid7's threat intelligence integration flags emergent threats faster than you'd catch them manually. Skip this if your primary need is compliance checkbox scanning; InsightVM prioritizes risk reduction over policy attestation, which means weaker coverage for ID.RA asset discovery compared to tools that lean harder into continuous monitoring and configuration assessment.
Tool that immunizes Windows systems against critical vulnerabilities
VM solution with AI-driven prioritization and automated remediation workflows
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Rapid7 InsightVM for your vulnerability assessment needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). headquartered in China. Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..
Rapid7 InsightVM: VM solution with AI-driven prioritization and automated remediation workflows. built by Rapid7. headquartered in United States. Core capabilities include Agent-based and agentless scanning, Active Risk scoring model with AI-driven prioritization, Dynamic asset discovery..
Both serve the Vulnerability Assessment market but differ in approach, feature depth, and target audience.
Get strategic cybersecurity insights in your inbox